Detalhe da pesquisa
1.
Population-based study of disease trajectory after radical treatment for high-risk prostate cancer.
BJU Int
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621388
2.
Safety and efficacy of apalutamide in Japanese patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo-controlled, phase III TITAN study.
Int J Urol
; 29(6): 533-540, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293030
3.
A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines.
Breast J
; 19(3): 240-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23528159
4.
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study.
Eur J Cancer
; 193: 113290, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708629
5.
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry.
Target Oncol
; 16(3): 357-367, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826036
6.
Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry.
Target Oncol
; 15(3): 301-315, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500294
7.
Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study.
Eur Urol
; 77(3): 380-387, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31594705
8.
Combination chemotherapy of vinorelbine and cisplatin: a phase I pharmacokinetic study in patients with metastatic solid tumors.
Anticancer Res
; 29(2): 553-60, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19331202
9.
Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 Study.
JAMA Oncol
; 5(8): 1159-1167, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31246234
10.
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923850